Critical R&D investments, rigorous clinical trials, access to capital, ongoing regulatory hurdles—these are only some of the key challenges Life Science companies face. At Woodruff Sawyer, we offer customized solutions to tackle these and other unique industry risks, through the most thorough discovery process in the industry.
Dedicated to the Life Sciences industry for almost 30 years, we’re more than an insurance broker; we’re a trusted business advisor to some of the world’s most innovative Life Science companies, with one of the largest client portfolios in the industry. From product and clinical trials liability, to supply chain risk, D&O liability, and employee benefits, we are your advocate to protect all aspects of your business, in every part of the world where you operate.
Safeguarding Science By Sector
- Biotechnology
- Pharmaceutical
- Medical Device
- Digital Health
- Diagnostics
- Supply Chain Providers
INSIGHTS
INSIGHTS
What’s Trending in Securities Class Actions for Life Sciences?
Sidley Austin LLP puts out an informative yearly report diving into securities class actions in the life sciences sector and critical court rulings from 2019.
INSIGHTS
INSIGHTS
Coronavirus: Pharmaceutical Supply Chain Disruptions and Product Shortages
The vulnerability of the US pharmaceutical supply chain has once again been exposed, this time due to complications from the spreading Coronavirus. Find out what you can do to mitigate your supply chain disruption risk.
